Medipharm Labs Corp T.LABS

If you haven’t listened to Earnings call…

[alleyesonme]

At least read the transcript....https://seekingalpha.com/article/4680820-medipharm-labs-corp-medif-q4-2023-earnings-call-transcript

[mdjbrown]

Thank you for posting the link alleyesonme That has to be the most transparent Conference Call by Medipharm execs that I have heard in years. Lots going on behind the scenes and it looks like they have finally decided to share in their story  with the markets. Bodes well for a really prosperous 2024

[Starkicker]

Thanks for posting the link. Interesting read. Definitely on solid footing but nothing that's going to trigger any kind of explosive growth in the share price, especially fromthe pharma side. As Keith discussed previously, pharmaceutical revenue is a longer-term strategy and will take time to pay off as clinical trials progress and applications make their way through the long-term process of

[QContinuum1]

Exactly this.  And I hope now we can move away from the 52 strong and late stage clinical trial nonsense as they now have put a bullet square in the head of that. That said, the transcript was very telling and provided some fairly positive feel, but as has come LABS standard, it was almost all sizzle and no real steak.  Lots of the expected 'soon's and 'expected's etc

[Starkicker]

The moment I hear any mention of RS I am gone.

[Lvlchange]

Agree.  

[okgonow]

when did anyone say anything about a RS did i miss something????? also $.09 seems to be the new $.07..... hope this dosent go on for as long as the $.07 lasted

[subaru1]

Totally agree with you and the stock price is reflecting exactly it. First qrt should show around 11 millions of revenue and Ebitda around (500k) if there is a change in tht taxes we will become EPS positive in the second qrt. I hope that there is no RS that would be the worst thing to do. If there is no major development in the coming month  i see the stock staying around $0,75 to $0,09